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The NF-κB signaling pathway is central to the body’s response to many pathogens. Math-
ematical models based on cell culture experiments have identiﬁed important molecular
mechanisms controlling the dynamics of NF-κB signaling, but the dynamics of this path-
way have never been studied in the context of an infection in a host. Here, we incorporate
these dynamics into a virtual infection setting.We build a multi-scale model of the immune
response to the pathogenMycobacterium tuberculosis (Mtb) to explore the impact of NF-κB
dynamics occurring acrossmolecular, cellular, and tissue scales in the lung. NF-κB signaling
is triggered via tumor necrosis factor-α (TNF) binding to receptors on macrophages; TNF
has been shown to play a key role in infection dynamics in humans andmultiple animal sys-
tems. Using our multi-scale model, we predict the impact ofTNF-induced NF-κB-mediated
responses on the outcome of infection at the level of a granuloma, an aggregate of immune
cells and bacteria that forms in response to infection and is key to containment of infec-
tion and clinical latency. We show how the stability of mRNA transcripts corresponding
to NF-κB-mediated responses signiﬁcantly controls bacterial load in a granuloma, inﬂam-
mation level in tissue, and granuloma size. Because we incorporate intracellular signaling
pathways explicitly, our analysis also elucidates NF-κB-associated signaling molecules and
processes that may be new targets for infection control.
Keywords: tuberculosis, granuloma, NF-κB signaling pathway, tumor necrosis factor, systems biology, multi-scale
modeling
INTRODUCTION
The transcription factor NF-κB is a central inﬂammatory medi-
ator that is essential for the induction of a variety of inﬂamma-
tory genes in response to various pathogens and inﬂammatory
cytokines. One such cytokine is tumor necrosis factor-α (TNF), a
key regulator of host responses to infection, in particular immune
response to Mycobacterium tuberculosis (Mtb), the causative agent
of tuberculosis (TB). TNF affects the immune response to Mtb
through several mechanisms, including induction of macrophage
activation to efﬁciently kill bacteria (Gutierrez et al., 2008; Harris
et al., 2008; Mosser and Edwards, 2008), induction of chemokine
and cytokine expression (Algood et al., 2004), and apoptosis (Beg
and Baltimore, 1996; Van Antwerp et al., 1996; Keane et al., 1997,
2002). These activities, regulated by the NF-κB signaling pathway,
have made TNF a key factor for restricting bacterial growth in
granulomas, aggregates of bacteria and immune cells within the
lung that form as a result of the immune response (Algood et al.,
2003; Turner et al., 2003; Ulrichs et al., 2004; Lin et al., 2006;Morel
et al., 2006; Tsai et al., 2006; Davis and Ramakrishnan, 2008).
Hence, the TNF-induced NF-κB signaling pathway is central to
the Mtb immune response, and regulation of intracellular NF-κB
signaling dynamics may be key to controlling Mtb infection.
Granulomas are the key pathological feature of TB. If gran-
ulomas are capable of containing mycobacteria growth and
spread, humans develop a clinically latent infection (Flynn and
Klein, 2010; Russell et al., 2010; Flynn et al., 2011). However, if
granulomas are impaired in function, infection progresses, gran-
ulomas enlarge, and bacteria seed new granulomas; this results in
progressive pathology anddisease, i.e., activeTB. In clinical latency,
immunologic perturbation at the level of the granuloma can result
in reactivation of infection (Lin et al., 2010). Several experimental
(Flynn et al., 1995; Bean et al., 1999;Roach et al., 2002;Chakravarty
et al., 2008; Clay et al., 2008; Lin et al., 2010) and theoretical
(Marino et al., 2007, 2012; Ray et al., 2009; Fallahi-Sichani et al.,
2010, 2011, 2012) studies have conﬁrmed the principal role of TNF
in containment of bacteria within TB granulomas.
NF-κB in resting cells is bound to IκB proteins that hold
it latent in cytoplasm. Binding of TNF to TNF receptor type
1 (TNFR1) results in activation of IκB kinase (IKK) and IKK-
mediated phosphorylation of IκB proteins that ultimately leads
to ubiquitination and proteasome-mediated degradation of IκB.
Free NF-κB then accumulates in the nucleus and mediates the
transcription of target genes (Hayden and Ghosh, 2008; Balti-
more, 2011). These genes include extracellular signaling mole-
cules such as TNF and chemokines, intracellular proteins such as
macrophage-activating molecules (referred to here as ACT) and
inhibitor of apoptosis proteins (IAPs), as well as negative regula-
tors of NF-κB such as IκBα and A20 (Pahl, 1999; Hoffmann and
Baltimore, 2006; Gutierrez et al., 2008). The inhibitory impact of
A20 on NF-κB results from its roles in attenuating TNFR1 activity
and inhibiting IKK activation (Wertz et al., 2004). The regulation
of NF-κB via multiple critical intracellular feedback mechanisms
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is important for the control of inﬂammation and immune acti-
vation (Hoffmann et al., 2002; Cheong et al., 2006, 2008; Kearns
and Hoffmann, 2009). Further, the structural characteristics of
the inﬂammatory genes induced by NF-κB, particularly stability
of their corresponding mRNA transcripts, control the dynamics
of NF-κB-mediated responses in cells (Hao and Baltimore, 2009).
However, the signiﬁcance of intracellular molecular mechanisms
controlling the dynamics of TNF-induced NF-κB signaling in reg-
ulating the long-term immune response toMtb infection is poorly
characterized.
One can hypothesize that molecules such as NF-κB that have
been shown to be critical to immunity against Mtb may have sig-
niﬁcant effects at the cell and tissue scale, namely on the formation
and function of granulomas (Barry et al., 2009; Kirschner et al.,
2010). However, these effects have not been identiﬁed. For exam-
ple, it is unclear how the dynamics of NF-κB-mediated responses
(i.e., expression of chemokines, TNF and IAPs, and activation of
macrophages) affect formation and function of a granuloma. A
critical requirement for such studies is the integration of biological
information across multiple biological scales (molecular, cellular,
and tissue; Figure 1). In this study, we describe a multi-scale com-
putationalmodel that includes: (i)molecular interactions describ-
ing the dynamics of the TNF-induced NF-κB signaling pathway,
(ii)molecular interactions describing the dynamics of TNFRbind-
ing and trafﬁcking, and (iii) cellular/tissue-scale dynamics of the
immune response to Mtb. These processes altogether lead to for-
mation of a granuloma. We incorporate a recent model of the
NF-κB pathway developed by Tay et al. (2010) based on cell cul-
ture data but never explored in the context of an infection in a
host. We show that dynamics of TNF-induced NF-κB signaling
are critical to controlling bacterial load and inﬂammation levels
at the tissue scale. Further, TNF-mediated activation of resting
macrophages, in addition to infected macrophages, is required
for a protective immune response, but must be optimally regu-
lated by the immune system to prevent excessive inﬂammation.
We also predict the impact of the dynamics (the extent and the
timing) of various NF-κB-mediated responses (i.e., expression of
chemokines, TNF, IAPs, and activation of macrophages) on both
formation and function of a granuloma. Finally, we ask whether
pharmacologicallymanipulating theNF-κB signalingpathway (for
example, by affecting mRNA stability) can improve the outcome
of a granuloma that is initially unable to control infection.
MATERIALS AND METHODS
MULTI-SCALE GRANULOMA MODEL
To address questions regarding TNF-regulated host immune
responses to Mtb infection in the lung and the impact of NF-κB
signaling dynamics on these responses, we developed a multi-
scale computational model (Figure 1) that describes processes
over three biological length scales: tissue, cellular, and molecular.
Cellular and tissue-scale dynamics are captured via probabilistic
rules for interactions between immune cells and Mtb using a sto-
chastic two-dimensional agent-based model (ABM). Single-cell
level molecular scale processes include TNF/TNFR binding and
trafﬁcking events (deﬁned here to include synthesis, internaliza-
tion, recycling, and degradation of ligand and receptors) as well as
intracellular NF-κB signaling pathway interactions and reactions
that are captured by non-linear ordinary differential equations
(ODEs).We brieﬂy describe thesemodels below and then describe
our approach for linking them.
Our ABM builds on our previous models that capture cel-
lular scale interactions leading to a tissue-level readout, namely
granuloma formation in response to Mtb infection in primates
(Segovia-Juarez et al., 2004; Ray et al., 2009; Fallahi-Sichani et al.,
2011). The ABM has the following components: agents (immune
cells, bacteria, chemokines, and cytokines), the environment where
agents reside (a two-dimensional grid representing a section of
lung tissue), probabilistic rules that govern the dynamics of agents,
including movement, actions, and interactions among agents and
between agents and environment, and time-scales on which the
rules are executed. Brieﬂy,ABMevents include: chemotacticmove-
ment and recruitment of immune cells from vascular sources to
site of infection, intracellular and extracellular growth of Mtb,
phagocytosis of bacteria bymacrophages, cell death and apoptosis,
macrophage/T-cell interactions such as cytolytic functions of cyto-
toxic T cells (Tc) and IFN-γ-mediated activation of macrophages
by pro-inﬂammatory T cells (Tγ), down-regulation of immune
cells by regulatory T cells (Treg), diffusion of chemokines and
soluble TNF (sTNF), and caseation (formation of an area of
dead tissue with a cheese-like appearance in the center of gran-
uloma). Some of the ABM rules are shown in Figure 1A and a
detailed description of these aspects of ABM structure and rules
can be found in Fallahi-Sichani et al. (2011). ABM parameters
that reﬂect known biological activities are provided in Table A1 in
Appendix. We have now modiﬁed our ABM described in Fallahi-
Sichani et al. (2011) to facilitate its linking to an NF-κB signaling
dynamics model. We now include NF-κB-mediated macrophage
activation, NF-κB-mediated chemokine and TNF expression, and
NF-κB-mediated inhibition of apoptosis. All of these activities
are now controlled as part of the NF-κB signaling dynamics
model.
The ODE model describing kinetic processes of TNF/TNFR
binding and trafﬁcking occurring in individual cells follows our
previous models (Fallahi-Sichani et al., 2010, 2011; Figure 1B;
Tables A2 and A3 in Appendix). We modiﬁed the reactions asso-
ciated with TNF expression in this model to capture the linkage
between this process and the NF-κB signaling pathway.
In order to capture the molecular mechanisms that control
TNF-mediated responses at the single-cell level, we ﬁrst need
to have a model describing intracellular NF-κB signaling path-
way activation that follows TNFR activation due to TNF binding.
Then, NF-κB activation must be linked to each of the NF-κB-
mediated cell responses that include macrophage activation and
expression of chemokines, TNF and IAPs. The single-cell level
intracellular NF-κB signaling pathway interactions and reactions
are captured by using the deterministic approximation of the
two-compartment NF-κB dynamics model presented by Tay et al.
(2010). This model combines the two-feedback NF-κB-IκBα-A20
regulatory module with the signal transduction cascade trans-
mitting the signal from sTNF-bound TNFR1 receptors. TNFR1
activation results in an oscillatory NF-κB response that controls
the dynamics of gene expression (Nelson et al., 2004). The model
includes noise due to different levels of TNFRs and total NF-
κB molecules across the cell population. This noise results from
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FIGURE 1 | Schematic diagram of the multi-scale model of the
immune response to Mtb infection in the lung. (A) An overview of
selected cell- and tissue-level ABM rules based on known immunological
activities and interactions (Mr, resting macrophage; Mi, infected
macrophage; Mci, chronically infected macrophage; Ma, activated
macrophage; Tγ, pro-inﬂammatory IFN-γ producingT cell; Tc, cytotoxic T
cell). Example rules are: (I) infection of a resting macrophage after
phagocytosis of extracellular Mtb, (II) intracellular growth of Mtb within an
infected macrophage, (III) cytotoxic T cell-mediated killing of an infected
macrophage, (IV) activation of a macrophage as a result of interaction with
IFN-γ producingT cells andTNF, (V) secretion of TNF (and chemokines)
from an activated macrophage and diffusion in tissue, (VI) TNF interactions
with a macrophage and induction of feedback mechanisms that control
TNF-mediated cell responses. For a full description of all ABM rules (see
Fallahi-Sichani et al., 2011). (B) An overview of TNF/TNFR binding and
trafﬁcking interactions and reactions and the NF-κB signal transduction
cascade at the level of individual cell. TNF/TNFR-associated processes are
modeled in both macrophages andT cells. (C) Detailed description of the
regulation of theTNF-induced NF-κB signaling pathway and
NF-κB-mediated responses [expression of chemokines (CHEM), TNF,
inhibitors of apoptosis (IAP), and macrophage-activating molecules (ACT)]
for an individual macrophage.
random assignment of initial values for TNFR densities and total
NF-κBmolecules to each single cell as described inTay et al. (2010).
In this study, we link the molecular scale NF-κB dynam-
ics model described above to four major NF-κB-mediated cell
responses in macrophages (Figure 1C). These responses are:
TNF expression, chemokine expression, macrophage activation,
and inhibition of apoptosis. To do this, we incorporate NF-κB-
mediated expression of genes corresponding to TNF, chemokines,
a generic IAP, and a generic macrophage-activating molecule
(ACT), translation of their mRNA transcripts, and secretion of
translated TNF and chemokines into the single-cell level NF-κB
dynamics model. The generic IAP represents a family of proteins
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that serve as inhibitors of apoptosis (e.g., cellular inhibitors of
apoptosis, c-IAPs) via binding and inhibiting caspase activities
(Karin and Lin, 2002). The generic ACT represents various mole-
cules (e.g.,membrane trafﬁcking molecules or lysosomal enzyme)
that are induced by NF-κB and are required for activation of a
macrophage to efﬁciently kill bacteria (Gutierrez et al., 2008). The
reactions, parameters, and equations describing intracellular NF-
κB signaling pathway processes and NF-κB-mediated responses
for an individual cell are listed in Tables A4–A6 in Appendix. The
full range of parameter values explored is given in Table A5 in
Appendix; values in parentheses indicate baseline model values,
which are intermediate values in the ranges explored and yield the
containment outcome.
LINKING THE SINGLE-CELL MOLECULAR SCALE NF-κB SIGNALING
DYNAMICS TO THE TNF/TNFR KINETIC MODEL AND THE
CELLULAR/TISSUE-SCALE MODEL
The activation of TNF-induced NF-κB signaling pathway requires
sTNF binding to cell surface TNFR1. It is this process that links
the TNF/TNFR kinetic model to the intracellular NF-κB signaling
dynamics model. The activation of the NF-κB signaling pathway
initiates four major cellular responses: induction of chemokine
expression, TNF expression, macrophage activation (to efﬁciently
kill bacteria), and inhibition of apoptosis. These responses serve
as the link between the single-cell molecular scale NF-κB signaling
dynamics model and the cellular/tissue-scale model (Figure 1).
Secretion of chemokines and TNF by macrophages into extracel-
lular spaces followsNF-κB-mediated expression of their genes and
translation of their mRNA transcripts as described in the NF-κB
signaling equations (see Tables A4 and A6 in Appendix). Recent
studies on NF-κB activation and apoptosis have shown that these
are processes with discrete nature at the single-cell level,withmore
cells responding to higher doses of stimuli and longer periods of
stimulation (Albeck et al., 2008; Tay et al., 2010). Accordingly, we
describe NF-κB-mediated activation of a macrophage as a Pois-
son process with a probability determined within each time-step
(Δt ), based on a Poisson rate parameter that is a function of
the macrophage activation rate constant (kACT), intracellular con-
centration of ACT protein [ACT], and the ACT concentration
threshold for macrophage activation (τACT):
Pactivation =
{
0 ; [ACT] < τACT
1 − e−kACT([ACT]−τACT)Δt ; [ACT] ≥ τACT (1)
Similarly, we model TNF-induced apoptosis for each individual
cell by:
Papoptosis ={
0 ; [sTNF/TNFR1i] < τapopt
1 − e−kapopt([sTNF/TNFR1i ]−τapopt)Δt ; [sTNF/TNFR1i] ≥ τapopt
(2)
We use a Poisson process with a probability computed as a func-
tion of the apoptosis rate constant (kapopt), the concentration of
internalized sTNF/TNFR1 complexes (sTNF/TNFR1i), and the
concentration threshold for internalized sTNF/TNFR1 (τapopt).
The inhibitory impact of the NF-κB activation on macrophage
apoptosis is captured by:
kapopt = kIAP
kIAP + [IAP]k
0
apopt (3)
The magnitude of kapopt is a function of the intracellular con-
centration of IAP, the apoptosis inhibition coefﬁcient (kIAP),
and the intrinsic TNF-induced apoptosis rate constant (k0apopt).
Parameters introduced in Eqs 1–3 are listed in Table A5 in
Appendix.
COMPUTER SIMULATIONS AND MODEL OUTPUTS
The multi-scale computational model is used to simulate the
immune response toMtb and granuloma formation in the lung for
200 days post-infection. Simulations are initiated following place-
ment of one infectedmacrophagewith one intracellular bacterium
at the center of a grid representing a section of lung tissue (see
Fallahi-Sichani et al., 2011 for details). Cell-cell interactions gov-
erned by ABM rules are updated within every ABM time-step
(Δt = 10min). Molecular scale processes, including TNF/TNFR
dynamics and NF-κB signaling dynamics at the single-cell level,
are updated within shorter time-steps (dt= 0.5 s).
We use several model outputs to track formation and function
of a granuloma during the immune response to Mtb. Granuloma
size and total number of macrophages and T cells in tissue are
used as readouts to track granuloma formation.We also track total
number of bacteria and total number of activated macrophages as
readouts for quantifying granuloma function. These outputs rep-
resent the ability of a granuloma to control infection and inﬂam-
mation, respectively. Other outputs of interest include chemokine
and TNF concentrations in tissue, and caseation area.
We previously showed that the efﬁcacy of TNF in controlling
Mtb infection is strongly affected by whether or not macrophages
stimulated by TNF are infected (Fallahi-Sichani et al., 2011). To
analyze how NF-κB signaling affects infected versus uninfected
(resting) macrophages in a granuloma, we deﬁne infected/resting
cell ratios, Rapoptosis and Ractivation, as follows. Rapoptosis is deﬁned
as the ratio of the number of infected macrophages that undergo
TNF-mediated apoptosis to the number of resting macrophages
that undergo TNF-mediated apoptosis during a 200-day period
post-infection. Ractivation is similarly deﬁned as the number of
infectedmacrophages that become activated (to efﬁciently kill bac-
teria) to the number of restingmacrophages that become activated
during a 200-day period post-infection.
PARAMETER ESTIMATION
We estimate ABM parameter values from literature data or by
using uncertainty analysis as described in detail in Marino et al.
(2008); Ray et al. (2009); Fallahi-Sichani et al. (2011). Cell-speciﬁc
TNFR densities and rate constants for TNF/TNFR processes are
estimated based on experimental data from our group (Fallahi-
Sichani et al., 2010) and other groups as indicated in Table A3
in Appendix. Intracellular NF-κB signaling parameters are as in
Tay et al. (2010; Table A5 in Appendix). Values of parameters
used to describe TNF-induced apoptosis and NF-κB-mediated
cell responses, including induction of expression of chemokines
Frontiers in Physiology | Computational Physiology and Medicine June 2012 | Volume 3 | Article 170 | 4
Fallahi-Sichani et al. NF-κB signaling in a tuberculosis granuloma
and TNF, macrophage activation and inhibition of apoptosis,
are estimated via uncertainty analysis. This is done by varying
parameter values in ranges that are consistent with experimental
and modeling data on time-scales of events associated with these
responses (Fotin-Mleczek et al., 2002; Rangamani and Sirovich,
2007; Albeck et al., 2008; Hao and Baltimore, 2009; Tay et al.,
2010). We specify a baseline set of parameter values (containment
baseline values as listed in Tables A1, A3, and A5 in Appendix)
that robustly leads to control of infection in granulomas with
organized structures as reported for humans and non-human
primates.
MODEL VALIDATION
Immunity to Mtb in humans and animal studies has been attrib-
uted to activities of a variety of factors, including speciﬁc immune
cells (e.g., macrophages and T cells), cytokines (e.g., TNF and
IFN-γ), chemokines (e.g., CCL2, CCL5, CXCL9/10/11), immune
receptors (e.g.,TNFR1), and signaling pathways (e.g.,NF-κB).Our
new multi-scale computational model [resulting from the incor-
poration of the single-cell level NF-κB signaling dynamics (Tay
et al., 2010), as indicated in Figure 1, into our previous genera-
tion model (Fallahi-Sichani et al., 2011)] must retain its ability
to reproduce experimental ﬁndings regarding the importance of
these factors in control of infection. Our model is able to reca-
pitulate different types of granuloma with different abilities to
control infection and inﬂammation (Figure 2). Using a baseline
set of values for model parameters (Tables A1, A3, and A5 in
Appendix), our model captures a state of equilibrium between
the host and Mtb termed bacterial containment (Figure 2A). This
state represents control of infection for more than 200 days within
a well-circumscribed granuloma containing stable bacteria num-
bers (<103 total bacteria). Simulated containment granulomas
closely represent experimentally characterized solid granulomas
(Algood et al., 2003; Turner et al., 2003; Ulrichs et al., 2004; Lin
et al., 2006; Morel et al., 2006; Tsai et al., 2006; Davis and Ramakr-
ishnan, 2008) that are predominantly composed of uninfected
macrophages surrounding a core of bacteria and infected and acti-
vated macrophages with T cells localized at the periphery. Varying
values of important model parameters lead to other possibilities,
including clearance of bacteria, uncontrolled growth of bacteria,
or excessive inﬂammation.
We also perform virtual deletion and depletion experiments
that mimic experimental gene knockout or molecule depletion
studies. Loss of activity is achieved by setting relevant parame-
ters (e.g., probabilities or rate constants) to zero or raising rele-
vant thresholds to an unattainable level. Virtual deletion refers to
the loss of activity from the beginning of simulation (such as a
gene knockout) and virtual depletion refers to the loss of activ-
ity after establishment of a granuloma. Speciﬁcally, we simulate
gene knockouts of previously identiﬁed essential components of
the Mtb immune response (e.g., TNF, TNFR1, IFN-γ, and T cell
knockouts). These simulation studies are used for testing the abil-
ity of the model to predict different infection outcomes under
pathological conditions compatible with both experimental and
previous modeling data on granuloma formation. Simulations of
TNF or TNFR1 knockout (Figure 2B), IFN-γ gene knockout, and
deletion of T cells (data not shown), in agreement with exper-
imental data and our previous modeling studies (Flynn, 2004;
Segovia-Juarez et al., 2004; Lin et al., 2007; Ray et al., 2009; Lin
and Flynn, 2010; Fallahi-Sichani et al., 2011), lead to uncontrolled
growth of Mtb and formation of granulomas with irregular struc-
tures that include very high numbers of extracellular bacteria, large
numbers of infected macrophages, and widespread caseation. In
contrast, inhibition of TNFR1 internalization, a process critical to
control of TNF concentration and apoptosis (Fallahi-Sichani et al.,
2010, 2011), leads to excessive inﬂammation by which we mean
recruitment of a large number of immune cells in tissue, uncon-
trolled activation of macrophages, and very high concentrations
of TNF (Figure 2C).
SENSITIVITY ANALYSIS
A second approach to identify important processes that determine
infection outcome is to use sensitivity analysis. We use sensitiv-
ity analysis to analyze the impact of parameters describing events
at different scales (molecular, cellular, or tissue scales) on model
outputs describing granuloma outcomes. In particular, we use
sensitivity analysis techniques adapted for use in ABMs (Marino
et al., 2008) to analyze the impact of NF-κB signaling-associated
FIGURE 2 | Examples of virtual control experiments for the multi-scale
computational model of granuloma formation in response to Mtb
infection. (A–C) Granuloma snapshots for (A) a scenario of containment
(200 days post-infection), (B) aTNFR1 knockout (TNFR1mac =TNFR1Tcell =0)
scenario resulting in uncontrolled growth of bacteria 200 days post-infection,
and (C) a scenario of blockingTNFR1 internalization (k int1 =0) resulting in
excessive inﬂammation 5weeks post-infection, respectively. All other model
parameter values used for these experiments are listed inTables A1,A3, and
A5 in Appendix. Cell types and status are shown by different color squares, as
indicated on the right side of the ﬁgure (Mr, resting macrophage; Mi, infected
macrophage; Mci, chronically infected macrophage; Ma, activated
macrophage; Be, extracellular bacteria; Tγ, pro-inﬂammatory IFN-γ producingT
cell; Tc, cytotoxic T cell; Treg, regulatory T cell). Caseation and vascular sources
are also indicated.
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parameter values on model outputs such as bacteria numbers,
macrophage and T cell numbers, chemokine and TNF concentra-
tions in tissue, granuloma size, and caseation area. Latin hypercube
sampling (LHS) is an algorithm that allowsmultiple parameters to
be varied and sampled simultaneously in a computationally efﬁ-
cient manner (Blower and Dowlatabadi, 1994). The correlation
of model outputs with each parameter is quantiﬁed via calcula-
tion of a partial rank correlation coefﬁcient (PRCC). PRCC values
vary between −1 (perfect negative correlation) and +1 (perfect
positive correlation) and can be differentiated based on p-values
derived fromStudent’s t test. Here,we performed 700-sample LHS
simulations for each parameter. Each sampled parameter set was
run four times (to account for stochasticity) and averages of the
outputs were used to calculate PRCC values. The choice of the
number of simulations is determined by the desired signiﬁcance
level for the PRCC (Blower and Dowlatabadi, 1994; Marino et al.,
2008). Here, 700 runs imply that PRCC values above +0.13 or
below −0.13 are signiﬁcantly different from zero (p < 0.001).
PROGRAMMING AND VISUALIZATION
The model was implemented in C++. We use Qt, a C++ frame-
work that runs our simulations on multiple platforms (Linux,
Windows, and Mac OS) with a graphical user interface (GUI).
Through the GUI, one can visualize and track different aspects
of the granuloma, including the structure and molecular con-
centration gradients, as the granuloma forms and is maintained.
Simulations can be run with or without graphical visualization.
For more detailed description of the Qt framework applications
in studying granuloma characteristics see (Marino et al., 2011).
RESULTS
CONTRIBUTION OF NF-κB SIGNALING FACTORS TO CONTROL OF
GRANULOMA OUTCOMES
Weknow fromboth experimental data and our previousmodeling
studies that TNF availability and activities (i.e., macrophage acti-
vation, induction of TNF and chemokine expression, regulation
of immune cell recruitment, and induction of apoptosis) within a
granuloma are essential to control of infection (Keane et al., 2001;
Winthrop, 2006; Marino et al., 2007; Chakravarty et al., 2008; Ray
et al., 2009; Lin et al., 2010; Fallahi-Sichani et al., 2011). TheNF-κB
signaling pathway activated as a result of TNF binding to TNFR1
on the membrane of immune cells is critical for regulation of
these activities. Having validated that our multi-scale model gives
results consistent with experimental data (seeMaterials andMeth-
ods, Figure 2), we now predict the role of biochemical factors
and interactions associated with the NF-κB signaling pathway on
important outcomes at the granuloma level: number of bacteria,
granuloma size and amount of caseation, and TNF concentration.
We analyze the impact of TNF-mediated NF-κB signaling-
associated parameters in six groups as deﬁned in Table A5
in Appendix: (1) concentration of intracellular signaling mole-
cules [NF-κB, IκBα kinase (IKK), and IKK kinase (IKKK)], (2)
processes associated with activation of the signal transduction
cascade, (3) A20 and IκBα synthesis, (4) IκBα interactions, (5)
NF-κB and IκBα transport between cytoplasm and nucleus, and
(6) NF-κB-mediated cell responses (TNF and chemokine expres-
sion, macrophage activation, inhibition of apoptosis). Notably,
parameters identiﬁed to have strong correlations with bacterial
levels within a granuloma, i.e., granuloma function, belong to
groups 1–3 and group 6 (see Table 1 and Tables A7 and A8 in
Appendix). Processes within groups 4 and 5, although essential for
NF-κB activation, have a less signiﬁcant impact on model outputs
as compared to other groups when they are all varied within a 10-
fold range around their baseline values.Within group 1, increasing
the average number of NF-κB molecules per macrophage signiﬁ-
cantly enhances macrophage activation and thus reduces bacterial
numbers within a granuloma. This is consistent with the pub-
lished data on the role of NF-κB in activating macrophages to kill
mycobacteria (Gutierrez et al., 2008). Similarly, IKKK activation
(from group 2), a key process in NF-κB signaling cascade that
occurs following TNF binding to TNFR1, strongly and negatively
correlates with bacterial load. Among group 3 parameters, the rate
of NF-κB binding at A20 and IκBα gene promoters as well as the
rates of A20 and IκBα mRNA synthesis and translation positively
correlate with bacterial levels. In contrast, increasingA20 and IκBα
mRNA and protein degradation rates impairs granuloma’s abil-
ity to control infection. These results highlight the important role
that the NF-κB-IκBα-A20 feedback regulatorymodule plays in the
regulation of the NF-κB-mediated cell responses (Cheong et al.,
2008), and thus in the regulation of granuloma function.
Finally, group 6 comprises important parameters with strong
effects on most model outcomes. Parameters that control either
TNF expression or macrophage activation signiﬁcantly inﬂuence
granuloma function and thus bacterial load within a granuloma.
In contrast, parameters that only affect chemokine expression
or apoptosis do control granuloma size (formation) but with-
out exerting strong effects on bacterial load (see Table 1 and
Table A8 in Appendix). This is consistent with our previous stud-
ies indicating that TNF-induced macrophage activation is a key
mechanism for controlling bacterial growth (Ray et al., 2009).
The rate of NF-κB-dependent mRNA synthesis for chemokines,
TNF, the generic macrophage-activating molecule (ACT), and
the inhibitor of apoptosis (IAP) is an important parameter. It
strongly and positively correlates with all TNF-induced cellular
responses in tissue (i.e., apoptosis, TNF and chemokine expres-
sion, and macrophage activation) and negatively correlates with
bacterial load, caseation, and granuloma size. The stability of TNF
mRNA, as well as TNF translation, degradation, and secretion
signiﬁcantly control granuloma outcomes. Increasing the rates
of degradation of TNF mRNA and intracellular TNF or reduc-
ing the rates of TNF translation and secretion enhance bacterial
numbers, caseation, and granuloma size. In addition, the ACT
translation rate (negatively), and the ACT degradation rate as
well as the ACT concentration threshold for macrophage acti-
vation (positively) correlate with bacterial load within a granu-
loma. Increasing the chemokine secretion rate or reducing the
chemokine mRNA degradation rate elevates chemokine con-
centration in tissue, enhancing immune cell recruitment, and
granuloma growth.
Overall, each of the above parameters identiﬁed as critical
for formation and function of a granuloma represents a poten-
tial target for therapeutic modulation. Hence, we focus our next
analysis on the potential effects of manipulation of each of these
parameters.
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Table 1 | NF-κB-associated model parameters significantly correlated with outputs of interest, i.e., bacterial numbers, granuloma size, caseation
area, andTNF concentration at day 200 post-infection.
NF-κB-associated
parameter*
Parameter description
†
(parameter group number
‡
)
Selected model outputs
Total number
of bacteria
Granuloma
size
Caseation Average tissue
concentration of
sTNF
NF-κBtot Average number of NF-κB molecules per cell (1) −− −
ka IKKK activation rate (2) −−
ki IKKK inactivation rate (2) +
q1 Rate of NF-κB binding at A20 and IκBα gene promoters (3) +
c1 Inducible A20 and IκBα mRNA synthesis rate (3) ++ +
c3 A20 and IκBα mRNA degradation rate (3) −−
c4 A20 and IκBα translation rate (3) ++ −−
c5 A20 degradation rate (3) −− ++
c1r Rate of NF-κB-induced mRNA synthesis for chemokines,
TNF, ACT, and IAP (6)
−− −− −− ++
c3rchem Chemokine mRNA degradation rate (6) −− ++
c4chem Chemokine translation rate (6) −−
e3chem Chemokine secretion rate (6) ++ −
c3rTNF TNF mRNA degradation rate (6) ++ ++ ++
c4TNF TNF translation rate (6) −− −− −− ++
c5TNF Intracellular TNF degradation rate (6) ++ ++ ++
e3TNF TNF secretion rate (6) −− −− −− ++
c4ACT ACT translation rate (6) −−
c5ACT ACT degradation rate (6) ++
τACT ACT concentration threshold for macrophage activation (6) ++
c5IAP IAP degradation rate (6) −− −− −
Detailed sensitivity analysis results are presented inTables A7 andA8 in Appendix.
*Only parameters with signiﬁcant PRCC values are indicated. Signiﬁcant positive and negative correlations are shown using + and − as follows: −/+: 0.001<p-
value<0.01, −−/++: p-value<0.001.
† IKKK, IKK kinase; IKK, IκBα kinase; ACT, generic macrophage-activating molecule; IAP, inhibitor of apoptosis.
‡NF-κB signaling-associated parameters are categorized in six groups as deﬁned inTableA5 in Appendix: (1) concentration of intracellular signaling molecules [NF-κB,
IκBα kinase (IKK), and IKK kinase (IKKK)], (2) processes associated with activation of the signal transduction cascade, (3) A20 and IκBα synthesis, (4) IκBα interactions,
(5) NF-κB and IκBα transport between cytoplasm and nucleus, and (6) NF-κB-mediated cell responses.
OPTIMAL REGULATION OF NF-κB SIGNALING DYNAMICS FOR CONTROL
OF INFECTION WITHOUT INDUCING EXCESSIVE INFLAMMATION
The analysis above highlights various NF-κB signaling pathway-
associated biochemical factors and intracellular interactions that
show signiﬁcant impacts on infection outcomes at all scales (mole-
cular, cellular, and tissue). How do these responses inﬂuence gran-
uloma formation? Does manipulation of these mechanisms alter
infection outcome at the granuloma level? The effects of manip-
ulation of four important NF-κB-associated factors as identiﬁed
by sensitivity analysis - (i) average number of NF-κB molecules
per cell, NF-κBtot, (ii) IKKK inactivation rate constant, ki, (iii)
A20 and IκBα mRNA degradation rate constant, c3, and (iv)
TNF mRNA degradation rate constant, c3rTNF - on granuloma
formation, total number of bacteria, sTNF concentration, and
macrophage activation after Mtb infection are shown in Figure 3.
The values of these parameters signiﬁcantly determine the
ability of a granuloma to control bacterial load. Small num-
bers of NF-κB molecules per cell, slow rates of A20 and IκBα
mRNA degradation, rapid rates of IKKK inactivation, and rapid
rates of TNF mRNA degradation all lead to uncontrolled growth
of bacteria within a 200-day period post-infection (Figure 3B).
These effects result from reduced rates of TNF-induced activa-
tion of macrophages, diminishing their ability to kill bacteria.
Slowly altering the values of these parameters to intermediate
levels reduces bacteria numbers and leads to containment of bac-
teria within a stable granuloma. Further increasing the values of
parametersNF-κBtot and c3, or further reducing the values of para-
meters c3rTNF and ki from their containment-level values each
further reduces bacterial numbers and increases the chance of
infection clearance. However, these clearance outcomes are gener-
ally accompanied by uncontrolled rates of macrophage activation
and cell inﬁltration as well as very high concentrations of TNF in
tissue; markers of excessive inﬂammation and immunopathology
(Figures 3C,D). Overall, as depicted in Figures 3A–D, intermedi-
ate (containment baseline) values of NF-κBtot, ki, c3 and c3rTNF
(listed in Table A5 in Appendix) lead to control of infection in
stable granulomaswith very lowbacteria numbers (and sometimes
clearance), low levels of TNF, and low levels of macrophage
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FIGURE 3 | NF-κB signaling dynamics control bacterial growth and
inflammation level in tissue. (A) Granuloma snapshots for slow
(ki =3.2×10−3 s−1), intermediate (ki =10−2 s−1), and rapid (ki =3.2×10−2 s−1)
rates of IKKK inactivation. Slow rates of IKKK inactivation lead to uncontrolled
macrophage activation and excessive inﬂammation. An intermediate value of ki
results in control of infection in a stable granuloma containing small numbers
of bacteria. Rapid rates of IKKK inactivation lead to large numbers of bacteria
and infected macrophages as well as widespread caseation. The colors
representing cells of different type and status in granuloma snapshots are the
same as those shown and deﬁned in Figure 2. (B–D) Simulation results
showing the effects of four important parameters, as identiﬁed by sensitivity
analysis, controlling NF-κB signaling dynamics on granuloma outcomes (total
number of bacteria, tissue concentration of TNF, and macrophage activation).
The parameters are: the average number of NF-κB molecules per cell (NF-κBtot),
IKKK inactivation rate (ki), A20 and IκBα mRNA degradation rate (c3), andTNF
mRNA degradation rate (c3rTNF). In each simulation, only one of these
parameters is varied. The baseline (intermediate) values of these parameters
lead to clearance or control of infection in stable granulomas with very low
bacterial numbers, low levels of TNF, and low levels of macrophage activation.
Perturbing the NF-κB signaling dynamics by varying values of these
parameters impair the balance toward either uncontrolled growth of bacteria
or excessive inﬂammation (highTNF concentrations and high levels of
macrophage activation) in tissue. The baseline value of each parameter is as
reported inTable A5 in Appendix and is as follows: NF-κBtot =105, ki =10−2 s−1,
c3 =7.5×10−4 s−1, c3rTNF =3.8×10−4 s−1. The difference between the low value
and high value presented in the ﬁgure is one order of magnitude.
activation. Perturbing NF-κB signaling dynamics by varying val-
ues of these parameters (i.e., rates at which these processes occur)
impairs the balance toward either uncontrolled growth of bacte-
ria or excessive inﬂammation in tissue. Hence, our model predicts
that the optimal regulation of the TNF-mediated NF-κB signaling
pathway is essential to controlling infection and inﬂammation in
tissue. The balance between the NF-κB-mediated bacterial killing
activities and the NF-κB-mediated inﬂammation results in an
equilibrium state, i.e., containment of bacteria within a stable
granuloma with minimal inﬂammation.
HOW DO NF-κB SIGNALING DYNAMICS BALANCE INFLAMMATION
AND BACTERIAL KILLING?
How do the NF-κB-associated intracellular processes identiﬁed
above affect the balance of inﬂammation and bacterial killing
activities within a granuloma? We previously showed that the
impact of TNF concentration on granuloma outcomes is strongly
correlated with whether or not macrophages stimulated by TNF
are infected (Fallahi-Sichani et al., 2011). This motivates us to test
whether there is a correlation between the effect of NF-κB signal-
ing dynamics on granuloma function (as described in Figure 3)
and the infection status of macrophages stimulated by TNF dur-
ing the immune response. Thus, we analyze the infection status
of macrophages that become activated or undergo apoptosis after
Mtb infection by computing infected/resting cell ratios, Ractivation
and Rapoptosis, as deﬁned in Section “Materials and Methods.”
Our model predicts a very signiﬁcant effect of important NF-κB-
associated parameters on both Ractivation and Rapoptosis (Figure 4).
At small numbers of NF-κB molecules per cell, slow rates of A20
and IκBα mRNA degradation, rapid rates of IKKK inactivation,
or rapid rates of TNF mRNA degradation, infected macrophages
are the main cells that become activated or undergo apoptosis as
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FIGURE 4 |The impact of important processes associated with the NF-κB
signaling dynamics on granuloma outcomes is correlated with status of
macrophages that undergo apoptosis or become activated byTNF.
Simulation results show the effect of (A) the average number of NF-κB
molecules per cell, NF-κBtot, (B) IKKK inactivation rate, ki, (C) A20 and IκBα
mRNA degradation rate, c3, and (D)TNF mRNA degradation rate, c3rTNF on
infected/resting cell ratios Rapoptosis and Ractivation within a 200 day period after
Mtb infection.
a result of TNF activities (Ractivation and Rapoptosis  1). However,
with one order of magnitude increase in each of these parameters,
resting macrophages become the main responders to TNF signal-
ing (Ractivation and Rapoptosis  1). Comparing these results with
results from the previous section (Figure 3), we observe a signiﬁ-
cant correlation between infected/resting cell ratios,Ractivation and
Rapoptosis, and the granuloma outcomes (i.e., bacterial load and
inﬂammation). At large values of Ractivation and Rapoptosis (values
of 1–10 or greater), we observe uncontrolled growth of Mtb. Small
values of these ratios (smaller than ∼0.1) correlate with excessive
inﬂammation in tissue. Intermediate values of infected/resting cell
ratios (between 0.1 and 1) are correlated with control of infec-
tion without excessive inﬂammation. The absolute values of these
ratios are calculated based on our two-dimensional simulations
and might change in three-dimensional settings. These results
suggest that a balance between the number of restingmacrophages
and infectedmacrophages responding to TNF signaling is required
for control of infection and inﬂammation within a stable granu-
loma, and that such a balance is critically regulated by NF-κB
signaling dynamics.
THE STABILITY OF mRNA TRANSCRIPTS CONTROLS BACTERIAL LOAD,
INFLAMMATION, AND GRANULOMA SIZE BY AFFECTING THE
DYNAMICS OF NF-κB-MEDIATED RESPONSES
A key advantage of incorporating NF-κB signaling dynamics
into our granuloma model is the ability to study the impact of
the dynamics of NF-κB-mediated responses (i.e., macrophage
activation, expression of chemokines, TNF, and inhibitors of
apoptosis) on granuloma outcomes. These responses follow NF-
κB oscillations (Nelson et al., 2004). The dynamics of these
responses depend, to a large extent, on the stability of their
corresponding mRNA transcripts (Hao and Baltimore, 2009).
Thus, we analyzed the effect of varying the stability of mRNA
transcripts corresponding to macrophage activation (ACT), and
expression of chemokines (CHEM), TNF, and inhibitors of
apoptosis (IAP) on granuloma outcomes, bacterial load, and
inﬂammation level (represented by the activated fraction of
macrophages). Varying the stability (half-life; t 1/2) of mRNA
transcripts signiﬁcantly inﬂuences the dynamics of the NF-κB-
mediated responses (e.g., chemokine secretion) in an individ-
ual cell (Figure 5A). Simulations show that the stability of
mRNA transcripts for NF-κB-mediated responses, particularly
ACT, TNF, and CHEM, signiﬁcantly control bacteria numbers
and inﬂammation level in tissue (Figures 5B,C). The impact
of the IAP mRNA stability on these model outcomes is less
signiﬁcant.
Our analysis shows that there are combinations of TNF,
ACT, CHEM, and IAP mRNA transcript half-lives that lead to
distinct model outcomes such as control of infection within sta-
ble granulomas, clearance, uncontrolled growth of bacteria, or
excessive inﬂammation (see Figure 2). For example, a contain-
ment outcome (as highlighted by yellow stars in Figures 5B,C)
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FIGURE 5 |The stability of mRNA transcripts controls bacterial load and
inflammation by affecting the dynamics of NF-κB-mediated responses.
(A)The effect of the stability (half-life) of chemokine mRNA transcripts
[t 1/2(CHEM)] on the dynamics of chemokine secretion by an individual cell.
Simulated results are produced using the single-cell level NF-κB signaling
dynamics model for continuous stimulation of a cell by 1 ng/ml TNF, with
parameters and equations as described inTables A3,A5, andA6 in
Appendix. A similar pattern of response can be observed when the effects
of mRNA stability on the dynamics of other NF-κB-mediated responses (i.e.,
expression of ACT, IAP, andTNF) are studied (data not shown). (B,C)
Simulation results for the effect of the stability of mRNA transcripts
corresponding to major NF-κB-mediated responses, including macrophage
activation [t 1/2(ACT)], TNF expression [t 1/2(TNF)], chemokine expression
[t 1/2(CHEM)], and inhibitor of apoptosis protein expression [t 1/2(IAP)], on
bacteria numbers (B) and on the activated fraction of macrophages (C)
200days post-infection. Small squares represent different values of
t 1/2(CHEM) vertically and different values of t 1/2(TNF) horizontally. Large
boxes represent different values of t 1/2(ACT) vertically and different values of
t 1/2(IAP) horizontally. Four values of mRNA half-life were tested in
simulations: 12min, 30min, 1 h, and 3 h. Simulation results were averaged
over 10 repetitions. Yellow stars represent an example scenario with
containment outcome. This state represents control of infection for more
than 200 days within a well-circumscribed granuloma containing stable
bacteria numbers (<103 total bacteria). Red stars represent an example
scenario that leads to clearance of Mtb (total bacteria=0) without inducing
excessive inﬂammation (activated fraction of macrophages <0.15).
may result from the following parameter combination: mRNA
transcript half-life of 30min for TNF, mRNA transcript half-life
of 1 h for ACT, mRNA transcript half-life of 1 h for CHEM, and
mRNA transcript half-life of 30min for IAP. Increasing mRNA
transcript stabilities for TNF and ACT from these values increases
the chance of extensive inﬂammation in tissue, whereas reduc-
ing their values signiﬁcantly enhance bacterial load. Increasing
mRNA transcript stabilities for CHEM from the suggested value
also slightly enhances bacterial load as well as granuloma size (data
not shown). Further, our results suggest that there are combina-
tions of mRNA stabilities for TNF-mediated responses that lead
to clearance of Mtb without inducing excessive inﬂammation (see
red stars in Figures 5B,C as an example). This set of mRNA sta-
bility values signiﬁcantly enhances the ability of granuloma to kill
bacteria while limiting inﬂammation by controlling macrophage
activation and apoptosis. Overall, these results suggest that the dif-
ferential dynamics of NF-κB-mediated responses resulting from
differential stabilities of their corresponding mRNA transcripts
are essential to regulate granuloma’s ability to control infection
and inﬂammation.
THE TIMING OF NF-κB-INDUCED MACROPHAGE ACTIVATION IS
CRITICAL TO CONTROLLING EXCESSIVE INFLAMMATION
In the previous section, we showed that stability of mRNA tran-
scripts associated with NF-κB-mediated inﬂammatory molecules
signiﬁcantly affects the immune response to Mtb. The stability
of mRNA controls both the extent and the timing of NF-κB-
mediated responses in individual cells (Tay et al., 2010). However,
it is not clear whether it is mostly the extent of response, the
timing of response, or both that inﬂuence granuloma outcomes.
In other words, how important is the speed of each individual
macrophage’s response to TNF signals in determining the overall
function of a granuloma? To address this question, we analyzed
the effect on granuloma outcomes of varying the stability of ACT,
CHEM, TNF, and IAP mRNA transcripts while maintaining the
average extent of these responses at their containment baseline
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levels (determined in the previous section). To maintain the aver-
age extent of each response as its corresponding mRNA stability is
varied, we simultaneously vary another parameter associated with
a process downstream of mRNA translation. Parameters varied
to adjust the extent of the four NF-κB-mediated responses are:
TNF secretion rate (e3TNF), chemokine secretion rate (e3chem),
ACT concentration threshold for macrophage activation (τACT),
macrophage activation rate constant (kACT), and apoptosis inhi-
bition constant (kIAP). For example, we increase the chemokine
mRNA half-life [t 1/2(CHEM)] and decrease the chemokine secre-
tion rate (e3chem) simultaneously to achieve the same average
numberof chemokinemolecules secreted in tissue by an individual
macrophage (Figure 6A).
Analysis of granuloma simulations indicates that among the
fourmajorNF-κB-mediated responses studied here (TNF,CHEM,
ACT, and IAP), only the timing of ACT response, i.e., macrophage
activation, is critical to control of inﬂammation in tissue as
well as bacterial load within a granuloma (Figures 6B,C). Early
NF-κB-mediated activation of macrophages that occurs because
of highly unstable ACT mRNA transcripts lead to uncontrolled
activation of macrophages and excessive inﬂammation in tissue.
This suggests that both extent and timing of NF-κB-mediated
macrophage activation are critical to control of the immune
response to Mtb.
CAN MANIPULATING TNF-MEDIATED NF-κB SIGNALING DYNAMICS
IMPROVE GRANULOMA FUNCTION?
Above we showed that optimal regulation of NF-κB signaling
dynamics is critical to control of infection within a granuloma
and control of inﬂammation in lung tissue. Thus, impairingNF-κB
activation leads to uncontrolled growth of bacteria that is in agree-
ment with NF-κB knockout experimental studies (Yamada et al.,
2001). The repression of NF-κB signaling in infectedmacrophages
is also a mechanism that pathogenic mycobacteria use to enhance
their survival and growth (Gutierrez et al., 2008). An important
question is then: can we ﬁnd a hypothetical treatment strategy that
FIGURE 6 |The timing of NF-κB-induced macrophage activation is critical
to control of inflammation. (A) Varying the chemokine mRNA half-life
[t 1/2(CHEM): 12min, 1 h, and 3 h, respectively] and the chemokine secretion
rate (e3chem: 7.65×10−5 s−1, 1.39×10−5 s−1, 4.52×10−6 s−1, respectively) by an
individual macrophage simultaneously leads to secretion of the same average
number of chemokine molecules, but with distinct temporal patterns of
chemokine secretion. Simulated results are produced using the single-cell
level NF-κB signaling dynamics model for continuous stimulation of a cell by
1 ng/ml TNF, with parameters and equations as described inTables A3,A5,
andA6 in Appendix. A similar pattern of response can be observed when the
effects of mRNA stability on the timing of other NF-κB-mediated responses
(i.e., expression of ACT, IAP, andTNF) are studied (data not shown). (B,C)
Simulation results for the effect of the timing of NF-κB-mediated responses,
including macrophage activation [regulated by t 1/2(ACT)], TNF expression
[regulated by t 1/2(TNF)], chemokine expression [regulated by t 1/2(CHEM)], and
inhibitor of apoptosis protein expression [regulated by t 1/2(IAP)], on bacteria
numbers (B), and on the activated fraction of macrophages (C) at 200 days
post-infection. Small squares represent different values of t 1/2(CHEM)
vertically and different values of t 1/2(TNF) horizontally. Large boxes represent
different values of t 1/2(ACT) vertically and different values of t 1/2(IAP)
horizontally. Four values of mRNA half-life were tested in simulations: 12min,
30min, 1 h, and 3 h. Simulation results were averaged over 10 repetitions.
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affects TNF-mediated NF-κB signaling in a granuloma to improve
ability to control bacteria? We ﬁrst simulate formation of a gran-
uloma that is unable to control bacterial growth due to impaired
NF-κB signaling (e.g., at high rates of IKKK inactivation, ki) for
100 days. Then, we change one or more of the NF-κB-associated
parameters to restore NF-κB activities within the granuloma and
resume simulation for another 100 days.
Our analysis, as depicted in Figure 7, indicates that reducing ki
(IKKK inactivation rate constant) fromhighvalues to intermediate
(containment-level) values (Treatment I) enhances the ability of a
granuloma to control bacteria. However, average bacteria levels for
a 200-day granuloma after changing ki are generally higher than
bacteria levels resulting from simulating a containment scenario.
A further decrease in the value of ki (Treatment II) ismore success-
ful in killing bacteria. However, it leads to uncontrolled activation
of macrophages and excessive inﬂammation in tissue. This sug-
gests that targeting the process of IKKK inactivation alone is not
sufﬁcient for infection control at the granuloma scale. In another
set of simulations (Treatment III), decreasing ki to intermediate
values, together with manipulating stability of mRNA transcripts
associated with NF-κB-mediated responses (based on results from
Figure 5) leads to better outcomes. Increasing the half-life of TNF
FIGURE 7 | Manipulation ofTNF-mediated NF-κB signaling for
improving granuloma function. Comparison of the dynamics of (A)
bacteria growth, (B) activated fraction of macrophages, and (C) granuloma
snapshots among three different treatment methods for enhancing NF-κB
activities. In all treatments, we ﬁrst simulate formation of a granuloma that
is unable to control bacteria growth due to impaired NF-κB signaling at
high rates of IKKK inactivation (ki =3.16×10−2 s−1) for 100 days (all other
parameter values are as listed inTables A1,A3, andA5 in Appendix). Then,
we change one or more of the NF-κB-associated parameters to restore
NF-κB activities within the granuloma and resume simulation for another
100 days. Parameter changes in each treatment are as follows: treatment I:
ki =1×10−2 s−1, Treatment II: ki =3.16×10−3 s−1, Treatment III:
ki =1×10−2 s−1, t1/2(TNF)=3h, t 1/2(ACT)=30min, t1/2(TNF)=1h.
Simulation results were averaged over 10 repetitions. The colors
representing cells of different type and status in granuloma snapshots are
the same as those shown and deﬁned in Figure 2.
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mRNA transcripts to 3 h, reducing the half-life of ACT mRNA
transcripts to 30min, and setting the IAP mRNA transcripts to
1 h improves the granuloma outcome, inducing efﬁcient killing
of bacteria without excessive inﬂammation. Overall, this suggests
that manipulating the dynamics of NF-κB-mediated responses,
particularly macrophage activation, TNF and IAP expression, can
improve the function of a TB granuloma.
DISCUSSION
Systems biology approaches have been increasingly helpful for
studying the interactions between the components of biological
systems, and understanding how these interactions give rise to the
function of the system. These approaches are particularly essential
for studying systems that consist of several components on differ-
ent spatial and temporal scales, as they are extremely challenging
to study using traditional experimental methods. An important
example is to study the role that the dynamics of intracellular
signaling pathways, with time-scales of seconds to hours, play in
the long-term immune response of a host to a pathogen. In this
work, we focus on this problem by asking if simulations of the
immune response can successfully capture both short and long-
term dynamics over length scales that range from molecular to
tissue. We build and simulate a multi-scale model to explore the
impact of NF-κB dynamics on the long-term immune response
to the pathogen Mtb. NF-κB plays an important role in coordi-
nating both innate and adaptive immunity. A recently published
study of the pathway uses data from cells in culture to elucidate
the kinetics of the pathway and to identify critical intracellular
mechanisms controlling the NF-κB response in a single cell (Tay
et al., 2010). A recent modeling study has also shown how NF-κB
response can control cytokine waves in tissue (Yde et al., 2011). Yet
it is unclear how these mechanisms affect the immune response in
tissue, where immune cells and bacteria interact with each other
and determine the outcome of infection.
Immune responses induced by Mtb infection are myriad and
complex, and it remains incompletely understoodwhich responses
are required for protection and which contribute to pathology
(Cooper, 2009; Lin and Flynn, 2010). Indeed, there is signiﬁ-
cant overlap among protective and pathological responses. An
important example, as dissected in this study, is TNF-induced
NF-κB activation. Figure 8 summarizes our results showing how
NF-κB-mediated responses are critical for restricting bacterial
growth in a granuloma, but excessive activation of the NF-κB
pathway in macrophages leads to pathological inﬂammation in
tissue. Containment of bacteria, particularly at the level of the
granuloma, is achieved when a balance exists between the NF-
κB-mediated bacterial killing activities and the NF-κB-mediated
inﬂammation. Such a balance is controlled by a combination
of molecular scale biochemical processes identiﬁed in detail in
this study, such as IKKK activity, A20 and IκBα interactions, and
stability of mRNA transcripts associated with NF-κB-mediated
responses. Optimal regulation of these processes, in the pres-
ence of an efﬁcient T cell-meditated response, can lead to clear-
ance of bacteria. Further, we ﬁnd that processes controlling the
dynamics of NF-κB signaling critically regulate whether resting
macrophages or infected macrophages are the major targets for
TNF signaling within a granuloma. Unless sufﬁcient numbers
FIGURE 8 | Optimal regulation of theTNF-mediated NF-κB signaling
dynamics is essential for optimal granuloma outcomes. Impaired NF-κB
activity leads to uncontrolled growth of bacteria within a granuloma
(outcome I). Containment or clearance of bacteria (outcome II) is achieved
when the NF-κB-mediated responses are regulated such that small, but
sufﬁcient numbers of macrophages become activated to kill bacteria.
Uncontrolled macrophage activation due to over-activity of NF-κB leads to
excessive inﬂammation in tissue (outcome III).
of resting macrophages relative to infected macrophages become
activated by TNF, uncontrolled growth of Mtb occurs. On the
other hand, excessive activation of resting macrophages leads to
uncontrolled inﬂammation. These ﬁndings highlight the poten-
tial importance of NF-κB-associated processes as targets in future
studies examining approaches to controlling both TB infection
and pathology.
Another interesting ﬁnding from our study is that the sta-
bility of mRNA transcripts corresponding to NF-κB-mediated
responses, particularly macrophage activation and expression of
TNF and chemokines, signiﬁcantly affects bacterial load in a gran-
uloma, inﬂammation level in tissue, and granuloma size. This
is due to the impact of mRNA stability on the kinetics of these
responses (Hao and Baltimore, 2009). Tay et al. (2010) have also
described how differences in stability of NF-κB-induced mRNA
transcripts and TNF concentration inﬂuence the dynamics of
expression of different inﬂammatory genes. We ﬁnd that both the
extent and the timing of NF-κB-mediated macrophage activation
are critical to control of the immune response toMtb.However, the
signiﬁcance of the stability of TNF and chemokine mRNA tran-
scripts ismostly due its effect on the extent of these responses. This
is the ﬁrst study, to our knowledge, that reveals the importance of
the dynamics of various NF-κB-mediated responses on immunity
toMtb. Further, we show that manipulating the dynamics of these
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responses in a granuloma that is unable to contain infection due
to, for example, pathogen-induced inhibition of NF-κB activation
can signiﬁcantly improve granuloma function.
Finally,our approach is an initial step towardunderstanding the
molecular targets at the level of intracellular signaling pathways for
control of the tissue-scale outcomes of the immune response to
Mtb, particularly granuloma formation. We anticipate that other
factors, including crosstalk between signalingmediated by theMtb
bacteria and other cytokines through various types of receptors
and different signaling pathways (Basak and Hoffmann, 2008) in
various types of cells, or the noise resulting from discrete regu-
lation of TNFR activity and transcription regulation (Lipniacki
et al., 2007) will further inﬂuence the ability of a granuloma to
contain infection. Importantly, our unique multi-scale approach
provides a platform for discovering which intracellular interven-
tions may enhance immunity to Mtb, and has implications for
testing and optimizing new vaccine and therapeutic strategies that
minimize non-speciﬁc or off-target side effects.
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APPENDIX
Table A1 |TNF-independent and cellular/tissue-scale parameters, definitions, and values estimated from literature or approximated via
uncertainty analysis as described in Ray et al. (2009); Fallahi-Sichani et al. (2011).
Parameter Parameter description Value*
Nsource Number of vascular sources 50
Ncaseum Number of qualiﬁed cell deaths required for caseation 10
Dchem (cm2/s) Diffusion coefﬁcient of chemokines 10−8–10−7 (5.2×10−8)
δchem (s−1) Chemokine degradation rate constant 10−4–10−3 (4.58×10−4)
τchem (molecules) Minimum chemokine concentration threshold 1–10 (2)
schem (molecules) Saturating chemokine concentration threshold 103–104 (2000)
M init Initial number of resident macrophages 105
maxageMac (day) Maximum lifespan of macrophages 100
maxageActive (day) Maximum lifespan of an activated macrophage 10
t regMac (h) Macrophage inactivity time after down-regulation byTreg 12
tmoveMr (min) Time interval for Mr movement 20
tmoveMa (h) Time interval for Ma movement 7.8
tmoveMi (h) Time interval for Mi movement 24
ωrecTNF Effect of TNF on cell recruitment 1
ωrecCCL2 Effect of CCL2 on cell recruitment 0.0507
ωrecCCL5 Effect of CCL5 on cell recruitment 0.0507
ωrecCXCL9/10/11 Effect of CXCL9 on cell recruitment 0.0254
N rk Number of extracellular Mtb engulfed by Mr or Mi 1
Pk Probability of Mr killing bacteria 0.01–0.1 (0.015)
BactM Number of extracellular Mtb activating a macrophage 50–150 (110)
Nc Number of intracellular Mtb for Mi →Mci transition 10
Nburst Number of intracellular Mtb that leads to Mci bursting 20–30 (20)
PSTAT1 Probability of STAT-1 activation in Mr or Mi 0.001–0.1 (0.085)
Nak Number of extracellular Mtb killed by Ma at each ABM time-step 10
τrecMac TNF/chemokine threshold for Mr recruitment 0.01–0.1 (0.023)
M recr Probability of Mr recruitment 0.01–0.1 (0.04)
maxageTcell (day) Maximum lifespan of T cells 3
tdelay (day) T cell recruitment delay 20
TmoveM Probability of T cell moving to a mac-containing location 0.001–0.1 (0.014)
TmoveT Probability of T cell moving to a T cell-containing location 0.001–0.1 (0.08)
T recr Probability of T cell recruitment 0.05–0.5 (0.15)
t regTgam (min) Tγ inactivity time after down-regulation byTreg 100
Papop/Fas Probability of Fas/FasL apoptosis by Tγ 0.01–0.1 (0.06)
τrecTgam TNF/chemokine threshold for Tγ recruitment 0.1–1.0 (0.4)
T recTgam Probability of Tγ recruitment 0.54
t regTcyt (min) Tc inactivity time after down-regulation byTreg 100
τrecTcyt TNF/chemokine threshold for Tc recruitment 0.1–1.0 (0.4)
T recTcyt Probability of Tc recruitment 0.36
PcytKill Probability of Tc killing Mi or Mci 0.02 0.2 (0.12)
PcytKillClean Probability of Tc killing all intracellular Mtb by killing Mci 0.75
τrecTreg TNF/chemokine threshold for Treg recruitment 0.01–0.1 (0.05)
T recTreg Probability of Treg recruitment 0.1
αBi (per 10min) Intracellular Mtb growth rate 2×10−4–2×10−3 (1.5×10−3)
αBe (per 10min) Extracellular Mtb growth rate 10−4–10−3 (7×10−4)
K be Capacity of a micro-compartment for extracellular Mtb 200
*Parameters used for sensitivity analysis are indicated by their ranges of values. Values in parentheses are used to generate containment baseline.
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Table A2 | Definition of reaction species, reactions describingTNF/TNFR processes and their rates (v i ).
REACTION SPECIES
mTNF Membrane-boundTNF sTNF/TNFR2 sTNF/TNFR2 complex on the membrane
sTNF Extracellular soluble TNF sTNF/TNFR1i Internalized sTNF/TNFR1 complex
TNFR1 Cell surfaceTNF receptor 1 sTNF/TNFR2i Internalized sTNF/TNFR2 complex
TNFR2 Cell surfaceTNF receptor 2 sTNF/TNFR2shed Shed sTNF/TNFR2 complex
sTNF/TNFR1 sTNF/TNFR1 complex on the membrane TNFi Intracellular translatedTNF
MODEL REACTIONS
1 mTNF expression
(T cells): v1 = ksynthTcell
(Macrophages): v1 =e3TNF[TNFi]
9 TNFR2 synthesis
v9 =V r2
2 mTNF→ sTNF
v2 = kTACE[mTNF]
10 TNFR1→TNFR1i
v10 = k t1[TNFR1]
3 sTNF+TNFR1↔ sTNF/TNFR1
v3 = kon1[sTNF][TNFR1]-koff1[sTNF/TNFR1]
11 TNFR2→TNFR2i
v11 = k t2[TNFR2]
4 sTNF+TNFR2↔ sTNF/TNFR2
v4 = kon2[sTNF][TNFR2]-koff2[sTNF/TNFR2]
12 sTNF/TNFR1i →degradation
v12 = kdeg1[sTNF/TNFR1i]
5 sTNF/TNFR1→ sTNF/TNFR1i
v5 = k int1[sTNF/TNFR1]
13 sTNF/TNFR2i →degradation
v13 = kdeg2[sTNF/TNFR2i]
6 sTNF/TNFR2→ sTNF/TNFR2i
v6 = k int2[sTNF/TNFR2]
14 sTNF/TNFR1i →TNFR1
v14 = k rec1[sTNF/TNFR1i]
7 sTNF/TNFR2→ sTNF/TNFR2shed
v7 = kshed[sTNF/TNFR2]
15 sTNF/TNFR2i →TNFR2
v15 = k rec2[sTNF/TNFR2i]
8 TNFR1 synthesis
v8 =V r1
16 sTNF/TNFR2shed → sTNF+TNFR2shed
v16 = koff2[sTNF/TNFR2shed]
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Table A3 | Molecular/single-cell scaleTNF/TNFR parameters, definitions and values estimated from literature.
Parameter Parameter description Value* Reference
ksynthTcell (#/cell.s) Full synthesis rate of mTNF for T cells 10−2–10−1 (0.021) Marino et al., 2007)
TNFR1mac (#/cell) TNFR1 density on the surface of
macrophages
500–5000 (1100–1900)
†
Fallahi-Sichani et al. (2010); Imamura et al. (1987);
Pocsik et al. (1994); van Riemsdijk-Van Overbeeke
et al. (2001)
TNFR1Tcell (#/cell) TNFR1 density on the surface of T cells 500–5000 (400–1200)
†
Fallahi-Sichani et al. (2010); Imamura et al. (1987);
Pocsik et al. (1994); van Riemsdijk-Van Overbeeke
et al. (2001)
TNFR2mac (#/cell) TNFR2 density on the surface of
macrophages
500–5000 (400–800)
†
Fallahi-Sichani et al. (2010); Imamura et al. (1987);
Pocsik et al. (1994); van Riemsdijk-Van Overbeeke
et al. (2001)
TNFR2Tcell (#/cell) TNFR2 density on the surface of T cells 500–5000 (600–800)
†
Fallahi-Sichani et al. (2010); Imamura et al. (1987);
Pocsik et al. (1994); van Riemsdijk-Van Overbeeke
et al. (2001)
D1 (cm2/s)
‡
Diffusion coefﬁcient of sTNF 10−8–10−7 (5.2×10−8) Nugent and Jain (1984); Pluen et al. (2001)
D2 (cm2/s)
‡
Diffusion coefﬁcient of shed
TNF/TNFR2 complex
10−8–10−7 (3.2×10−8) Nugent and Jain (1984); Pluen et al. (2001)
kTACE Mac (s−1) Rate constant for TNF release byTACE
activity on a macrophage
10−4–10−3 (4.4×10−4) Fallahi-Sichani et al. (2010); Newton et al. (2001);
Solomon et al. (1997); Crowe et al. (1995)
kTACETcell (s−1) Rate constant for TNF release byTACE
activity on aT cell
10−5–10−4 (4.4×10−5)
δTNF (s−1) sTNF degradation rate constant 10−4–10−3 (4.58×10−4) Cheong et al. (2006)
K d1 (M) Equilibrium dissociation constant of
sTNF/TNFR1
10−12–10−10 (1.9×10−11) Imamura et al. (1987); Grell et al. (1998)
K d2 (M) Equilibrium dissociation constant of
sTNF/TNFR2
10−10–10−9 (4.2×10−10) Imamura et al. (1987); Grell et al. (1998); Pennica
et al. (1992)
kon1 (M−1s−1) sTNF/TNFR1 association rate constant 107–108 (2.8×107) Grell et al. (1998)
kon2 (M−1s−1) sTNF/TNFR2 association rate constant 107–108 (3.5×107) Grell et al. (1998)
koff1 (s−1) sTNF/TNFR1 dissociation rate constant kon1 ×Kd1
koff2 (s−1) sTNF/TNFR2 dissociation rate constant kon2 ×Kd2
k int1 (s−1) TNFR1 internalization rate constant 1.5×10−4–1.5×10−3 (7.7×10−4) Grell et al. (1998); Higuchi and Aggarwal (1994)
k int2 (s−1) TNFR2 internalization rate constant 3.9×10−4–5×10−4 (4.6×10−4) Pennica et al. (1992)
kshed (s−1) TNFR2 shedding rate constant 3.9×10−4–1.5×10−3 (5×10−4) Crowe et al. (1995); Higuchi and Aggarwal (1994)
k rec1 (s−1) TNFR1 recycling rate constant 8.8×10−5–5.5×10−4 (1.8×10−5) Vuk-Pavlovic and Kovach (1989); Bajzer et al. (1989)
k rec2 (s−1) TNFR2 recycling rate constant 8.8×10−5–5.5×10−4 (1.8×10−5) Vuk-Pavlovic and Kovach (1989); Bajzer et al. (1989)
k t1 (s−1) TNFR1 turn-over rate constant 3×10−4–5×10−4 (3.8×10−4) Vuk-Pavlovic and Kovach (1989); Bajzer et al. (1989)
k t2 (s−1) TNFR2 turn-over rate constant 3×10−4–5×10−4 (3.8×10−4) Vuk-Pavlovic and Kovach (1989); Bajzer et al. (1989)
kdeg1 (s−1) TNFR1 degradation rate constant 10−5–10−4 (5×10−5) Imamura et al. (1987); Vuk-Pavlovic and Kovach
(1989); Bajzer et al. (1989); Tsujimoto et al. (1985)
kdeg2 (s−1) TNFR2 degradation rate constant 10−5–10−4 (5×10−5) Imamura et al. (1987); Vuk-Pavlovic and Kovach
(1989); Bajzer et al. (1989); Tsujimoto et al. (1985)
V r1 mac (#/cell.s) Cell surfaceTNFR1 synthesis rate
constant for macrophages
k t1 ×TNFR1mac
V r1 Tcell (#/cell.s) Cell surfaceTNFR1 synthesis rate
constant for T cells
k t1 ×TNFR1Tcell
V r2 mac (#/cell.s) Cell surfaceTNFR2 synthesis rate
constant for macrophages
k t2 ×TNF21mac
V r2 Tcell (#/cell.s) Cell surfaceTNFR2 synthesis rate
constant for T cells
k t2 ×TNF21Tcell
*Ranges of parameter values used for sensitivity analysis are indicated out of parentheses. Values in parentheses are used to generate baseline model results.
†Baseline model values for TNFR densities on each recruited individual cell was randomly chosen from the range shown in parentheses.
‡Diffusion coefﬁcients of the soluble species in granuloma were estimated in line with estimates for diffusible factors of similar molecular weight in tumors (Nugent
and Jain, 1984; Pluen et al., 2001).
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Table A4 | Definition of reaction species, reactions describing NF-κB signaling and response-associated processes in macrophages and their
rates (v i ).
REACTION SPECIES
sTNF/TNFR1 sTNF/TNFR1 complex on the membrane NFkB Cytoplasmic NF-κB
IKKn Neutral form of IKK kinase NFkBn Nuclear NF-κB
IKKa Active form of IKK A20 Translated A20
IKKi Inactive form of IKK A20t A20 transcript
IKKii Inactive intermediate form of IKK GA20 State of A20 gene
KNN Total number of IKK molecules (assumed
constant in time)
GIkB State of IκBα gene
IKKKa Active form of IKKK GR State of genes corresponding to
NF-κB-mediated responses
IKKKn Neutral form of IKKK chemi Intracellular translated chemokines
KN Total number of IKKK molecules (assumed to be
constant in time)
chemt Chemokine transcript
IkB Cytoplasmic IκBα TNFi Intracellular translatedTNF
IkBn Nuclear IκBα TNFt TNF transcript
IkBt IκBα transcript ACT Generic macrophage-activating molecule
IkBp Phosphorylated cytoplasmic IκBα ACTt ACT transcript
NFkB|IkB Cytoplasmic IκBα|NF-κB complex IAP Inhibitor of apoptosis protein
NFkB|IkBp Phosphorylated cytoplasmic IκBα in complex
with NF-κB
IAPt IAP transcript
NFkB|IkBn Nuclear IκBα|NF-κB complex
MODEL REACTIONS
17 IKKK kinase activation and activity attenuation
by A20
v17 = ka[sTNF/TNFR1].([KN] - [IKKKa]). KA20kA20+[A20]
42 Transport of NF-κB|IκBα complex out of nucleus
v42 =e2a[NFkB|IkBn]
18 Spontaneous inactivation of IKKKa
v18 = k i[IKKKa]
43 A20 gene activation due to NF-κB binding
v43 =q1[NFkBn](2− [GA20])
19 IKKii→ IKKn
v19 = k4([KNN]− [IKKn]− [IKKa]− [IKKi])
44 A20 gene inactivation due to removal of NF-κB
molecules by IκBα
v44 =q2[IkBn][GA20]
20 IKKn→ IKKa mediated by IKKKa
phosphorylation at two sites
v20 = k1[IKKKa]2[IKKn]
45 IκBα gene activation due to NF-κB binding
v45 =q1[NFkBn](2− [GIkB])
21 IKKa→ IKKi mediated by A20
v21 = k3[IKKa].(k2 + [A20])/k2
46 IκBα gene inactivation due to removal of NF-κB
molecules by IκBα
v46 =q2[IkBn][GIkB]
22 IKKi→ IKKii
v22 = k4[IKKi]
47 NF-κB-mediated response gene activation due
to NF-κB binding
v47 =q1r[NFkBn](2− [GR])
23 IκBα phosphorylation by IKKa
v23 = a2[IKKa][IkB]
48 NF-κB-mediated response gene inactivation due
to spontaneous removal of NF-κB molecules
v48 =q2rr[GR]
24 Degradation of phosphorylated IκBα
v24 = tp[IkBp]
49 NF-κB-mediated response gene inactivation due
to removal of NF-κB molecules by IκBα
v49 =q2r[IkBn][GR]
25 Phosphorylation of IκBα in complex with NF-κB
by IKKa
v25 = a3[IKKa][NFkB|IkB]
50 Constitutive transcription of TNF and
chemokines
v50 = c1rrchemTNF
26 Degradation of phosphorylated IκBα in complex
with NF-κB
v26 = tp[NFkB|IkBp]
51 NF-κB-dependent transcription of chemokines
andTNF
v51 = c1r[GR]
27 Liberation of free NF-κB due to degradation of
IκBα in their complex
v27 = c6a[NFkB|IkB]
52 Chemokine mRNA degradation
v52 = c3rchem[chemt]
(Continued)
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Table A4 | Continued
28 Formation of NF-κB and IκBα complex
v28 = a1[NFkB][IkB]
53 Chemokine translation
v53 = c4chem[chemt]
29 Transport of free cytoplasmic NF-κB to nucleus
v29 = i1[NFkB]
54 Intracellular chemokine degradation
v54 = c5chem[chemi]
30 Association of nuclear NF-κB with nuclear IκBα
v30 = a1kv[IkBn][NFkBn]
55 Chemokine secretion
v55 =e3chem[chemi]
31 A20 translation
v31 = c4[A20t]
56 TNF mRNA degradation
v56 = c3rTNF[TNFt]
32 Constitutive degradation of A20
v32 = c5[A20]
57 TNF translation
v57 = c4TNF[TNFt]
33 NF-κB inducible transcription of A20
v33 = c1[GA20]
58 Intracellular TNF degradation
v58 = c5TNF[TNFi]
34 Degradation of A20 transcript
v34 = c3[A20t]
59 Constitutive transcription of ACT
v59 = c1rrACT
35 IκBα translation
v35 = c4[IkBt]
60 ACT mRNA degradation
v60 = c3rACT[ACTt]
36 Constitutive degradation of IκBα
v36 = c5a[IkB]
61 ACT translation
v61 = c4ACT[ACTt]
37 Transport of IκBα into nucleus
v37 = i1a[IkB]
62 ACT degradation
v62 = c5ACT[ACT]
38 Transport of IκBα out of nucleus
v38 =e1a[IkBn]
63 Constitutive transcription of IAP
v63 = c1rrIAP
39 NF-κB inducible transcription of IκBα
v39 = c1[GIkB]
64 IAP mRNA degradation
v64 = c3rIAP[IAPt]
40 Degradation of IκBα transcript
v40 = c3[IkBt]
65 IAP translation
v65 = c4IAP[IAPt]
41 Association of NF-κB with IκBα in cytoplasm
v41 = a1[IkB][NFkB]
66 IAP degradation
v66 = c5IAP[IAP]
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Table A5 | Molecular/single-cell scale NF-κB signaling-associated parameters, definitions and values fromTay et al. (2010), or approximated via
uncertainty analysis.
Parameter Parameter description Value*
CONCENTRATION OF INTRACELLULAR SIGNALING MOLECULES
KN (#/cell) Number of IKKK molecules 3.16×104–3.16×105 (105)
KNN (#/cell) Number of IKK molecules 6.32×104–6.32×105 (2×105)
NF-κBtot (#/cell) Average number of NF-κB molecules 3.16×104–3.16×105 (105)
ACTIVATION OFTHE SIGNALTRANSDUCTION CASCADE
ka (s−1) IKKK activation rate 6.32×10−7–6.32×10−6 (2×10−6)
ki (s−1) IKKK inactivation rate 3.16×10−3–3.16×10−2 (10−2)
k1 (s−1) IKKn activation rate 1.9×10−10–1.9×10−9 (6×10−10)
kA20 (#/cell) Michaelis coefﬁcient in TNFR1 activity attenuation 3.16×104–3.16×105 (105)
k2 (#/cell) Michaelis coefﬁcient in IKKa inactivation 3.16×103–3.16×104 (104)
k3 (s−1) IKKn inactivation rate 6.32×10−4–6.32×10−3 (2×10−3)
k4 (s−1) IKKi→ IKKii and IKKii→ IKKn transformation 3.16×10−4–3.16×10−3 (10−3)
A20 AND IκBα SYNTHESIS
q1 (s−1) NF-κB binding at A20 and IκBα gene promoters 1.26×10−7–1.26×10−6 (4×10−7)
q2 (s−1) IκBα inducible NF-κB detaching from A20 and IκBα genes 3.16×10−7–3.16×10−6 (10−6)
c1 (s−1) Inducible A20 and IκBα mRNA synthesis 3.16×10−2–3.16×10−1 (10−1)
c3 (s−1) A20 and IκBα mRNA degradation 2.37×10−4–2.37×10−3 (7.5×10−4)
c4 (s−1) A20 and IκBα translation 1.58×10−1–1.58 (5×10−1)
c5 (s−1) A20 degradation rate 1.58×10−4–1.58×10−3 (5×10−4)
IκBα INTERACTIONS
a1 (s−1) IκBα-NF-κB association 1.58×10−7–1.58×10−6 (5×10−7)
a2 (s−1) IκBα phosphorylation 3.16×10−8–3.16×10−7 (10−7)
a3 (s−1) IκBα phosphorylation in IκBα|NF-κB complexes 1.58×10−7–1.58×10−6 (5×10−7)
tp (s−1) Degradation of phosphorylated IκBα 3.16×10−3–3.16×10−2 (10−2)
c5a (s−1) Spontaneous IκBα degradation 3.16×10−5–3.16×10−4 (10−4)
c6a (s−1) Spontaneous IκBα degradation in IκBα|NF-κB complexes 6.32×10−6–6.32×10−5 (2×10−5)
NF-κBAND IκBαTRANSPORT BETWEEN CYTOPLASMAND NUCLEUS
i1 (s−1) NF-κB nuclear import 3.16×10−3–3.16×10−2 (10−2)
e2a (s−1) IκBα|NF-κB nuclear export 1.58×10−2–1.58×10−1 (5×10−2)
i1a (s−1) IκBα nuclear import 6.32×10−4–6.32×10−3 (2×10−3)
e1a (s−1) IκBα nuclear export 1.58×10−3–1.58×10−2 (5×10−3)
kv Ratio of cytoplasmic to nuclear volume for a macrophage 5
NF-κB-MEDIATED CELL RESPONSESANDAPOPTOSIS
q1r (s−1) NF-κB binding at response gene promoters 3.16×10−8–3.16×10−7 (10−7)
q2r (s−1) IκBα inducible NF-κB detaching from response gene promoters 3.16×10−8–3.16×10−7 (10−7)
q2rr (s−1) Spontaneous NF-κB detaching from response gene promoters 3.16×10−4–3.16×10−3 (10−3)
c1r (s−1) Inducible response mRNA synthesis 0 (only resting macrophage), 1.58×10−2–1.58×10−1
(5×10−2)
c1rrchemTNF (s−1) Constitutive transcription rate for chemokines andTNF 0 (resting macrophage), 0.5× c1r (infected macrophage),
c1r (activated or chronically infected macrophage)
c3rchem (s−1) Chemokine mRNA degradation rate 6.1×10−5–6.1×10−4 (1.92×10−4)
c4chem (s−1) Chemokine translation rate 1.42×10−1–1.42 (4.5×10−1)
c5chem (s−1) Intracellular chemokine degradation rate 1.58×10−5–1.58×10−4 (5×10−4)
e3chem (s−1) Chemokine secretion rate 4.4×10−6–4.4×10−5 (1.39×10−5)
c3rTNF (s−1) TNF mRNA degradation rate 1.2×10−4–1.2×10−3 (3.8×10−4)
c4TNF (s−1) TNF translation rate 4.74×10−2–4.74×10−1 (1.5×10−1)
c5TNF (s−1) Intracellular TNF degradation rate 1.58×10−4–1.58×10−3 (5×10−4)
e3TNF (s−1) TNF secretion rate 7.87×10−7–7.87×10−6 (2.5×10−6)
c1rrACT (s−1) ACT mRNA constitutive synthesis rate 3.16×10−4–3.16×10−3 (1×10−3)
c3rACT (s−1) ACT mRNA degradation rate 6.1×10−5–6.1×10−4 (1.92×10−4)
(Continued)
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Table A5 | Continued
Parameter Parameter description Value*
c4ACT (s−1) ACT translation rate 1.58×10−1–1.58 (5×10−1)
c5ACT (s−1) ACT degradation rate 1.58×10−4–1.58×10−3 (5×10−4)
τACT (#/cell) ACT concentration threshold for macrophage activation 8–80 (25)
kACT [(#/cell)−1s−1] Macrophage activation rate constant 1.46×10−6–1.46×10−5 (7.7×10−6)
c1rrIAP (s−1) IAP mRNA constitutive synthesis rate 3.16×10−4–3.16×10−3 (1×10−3)
c3rIAP (s−1) IAP mRNA degradation rate 6.1×10−5–6.1×10−4 (1.92×10−4)
c4IAP (s−1) IAP translation rate 1.58×10−1–1.58 (5×10−1)
c5IAP (s−1) IAP degradation rate 1.58×10−4–1.58×10−3 (5×10−4)
k IAP (#/cell) Apoptosis inhibition coefﬁcient 1.22×101–1.22×102 (3.86×101)
k0apopt((#cell)
−1s−1) Intrinsic TNF-induced apoptosis rate constant 4.2×10−10–4.2×10−9 (1.33×10−9)
τapopt (#/cell) Internalized sTNF/TNFR1 threshold for TNF-induced apoptosis 50–500 (300)
*Parameters used for sensitivity analysis are indicated by their ranges of values. Values in parentheses are used to generate containment baseline.
†Baseline model values for intracellular NF-κBtot on each recruited individual macrophage was randomly based on a log-normal distribution as described in Tay et al.
(2010).
Table A6 | Differential equations describing molecular single-cell scaleTNF/TNFR and NF-κB signaling and response-associated processes.
d [mTNF]
d t
= v1 − v2 d [A20t]d t = v33 − v34
d [sTNF]
d t
= ( ρ
Nav
)(v2 − v3 − v4) + v16 d [IkB]d t = v23 − v28 + v35 − v36 − v37 + v38
d [TNFR1]
d t
= v8 − v3 − v10 + v14 d [IkBn]d t = −v30 + v37 − v38
d [TNFR2]
d t
= v9 − v4 − v11 + v15 d [IkBt]d t = v39 − v40
d [sTNF/TNFR1]
d t
= v3 − v5 d [NFkB|IkB]d t = v41 − v27 − v25 + v42
d [sTNF/TNFR2]
d t
= v4 − v6 − v7 d [NFkB|IkBn]d t = v30 − v42
d [sTNF/TNFR1i]
dt
= v5 − v12 − v14 d [GA20]d t = v43 − v44
d [sTNF/TNFR2i]
d t
= v6 − v13 − v15 d [GIkB]d t = v45 − v46
d [sTNF/TNFR2shed]
d t
=
(
ρ
Nav
)
v7 − v16 d [GR]d t = v47 − v48 − v49
d [IKKKa]
d t
= v17 − v18 d [chemt]d t = v50 + v51 − v52
d [IKKn]
d t
= v19 − v20 d [chemi]d t = v53 − v54 − v55
d [IKKa]
d t
= v20 − v21 d [TNFt]d t = v50 + v51 − v56
d [IKKi]
d t
= v21 − v22 d [TNFi]d t = v57 − v58 − v1
d [IkBp]
d t
= v23 − v24 d [ACTt]d t = v59 + v51 − v60
d [NFkB|IkBp]
d t
= v25 − v26 d [ACT]d t = v61 − v62
d [NFkB]
d t
= v27 − v28 + v26 − v29 d [IAPt]d t = v63 + v51 − v64
d [NFkBn]
d t
= v29 − v30 d [IAP]d t = v65 − v66
d [A20]
d t
= v31 − v32
In equations describing a reaction or interaction between a soluble molecule and a cell membrane-associated molecule, a scaling factor (ρ/Nav) is required as indicated
above, where ρ is the cell density in the ABMmicro-compartment and can be computed as (dx)−3 assuming that eachmicro-compartment is a cube of side dx=20μm.
Nav is the Avogadro’s number.
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Table A7 | LHS sensitivity analysis results for the effect of important NF-κB-associated model parameters (groups 1–3) on model outputs at day
200 post-infection.
NF-κBtot ka k i q1 c1 c3 c4 c5
TNF FUNCTION-RELATED OUTPUTS
(No. apoptosis)Macs
(No. apoptosis)Mr
(No. apoptosis)Mi and Mci −−
(No. apoptosis)Ma − +
(No. apoptosis)T cells + −− ++
(No. activation)Mr ++ ++ ++ −− ++
(No. activation)Mi −
CELLULAR-LEVEL OUTPUTS
Bint (intracellular Mtb) −− −−− + + + −−− ++ −−
Bext (extracellular Mtb) −− −−− + ++ −−− ++ −−
Btot (total Mtb) −− −−− + + ++ −−− ++ −−
Total macrophages
Mr −−− −−− +++ ++ +++ −−− +++ −−−
Mi and Mci −− −−− + + + −−− ++ −−
Ma + + ++ −− ++
Total T cells + + +
Tγ + − +
Tc + + − +
Treg + ++ + ++
TISSUE-LEVEL OUTPUTS
Caseation − +
Granuloma size
TISSUE CONCENTRATIONS
[sTNF]avg −− ++
[Chemokines]avg −− − +
Parameter deﬁnitions are presented inTable A5 in Appendix.
Only parameters with signiﬁcant PRCC values are indicated. Signiﬁcant positive and negative correlations are shown using ± as follows:
−/+, 0.001<p-value<0.01.
−−/++, 0.0001<p-value<0.001.
−−−/+++, p-value<0.0001.
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Table A8 | LHS sensitivity analysis results for the effect of important NF-κB-associated model parameters (group 6) on model outputs at day 200
post-infection.
c1r c3rchem c4chem e3chem c3rTNF c4TNF c5TNF e3TNF c4ACT c5ACT τACT c5IAP
TNF FUNCTION-RELATED OUTPUTS
(No. apoptosis)Macs +++ −− +++ −−− +++
(No. apoptosis)Mr +++ −−− +++ −−− +++
(No. apoptosis)Mi and Mci −− ++ −−− +++ −−− +++ +++
(No. apoptosis)Ma +++ +++ +++ ++ −− −
(No. apoptosis)T cells +++ −− +++ −−− +++ +
(No. activation)Mr +++ + +++ −−− −−−
(No. activation)Mi +++ ++ ++ − +++ −−− −−−
CELLULAR-LEVEL OUTPUTS
Bint (intracellular Mtb) −−− ++ −−− ++ −− −−− +++ +++
Bext (extracellular Mtb) −−− ++ −− ++ −− −−− +++ +++
Btot (total Mtb) −−− ++ −−− ++ −− −−− +++ +++
Total Macrophages −−− ++ +++ +++ −−− +++ −−− −
Mr −−− −− + +++ +++ −−− +++ −−− −−− +++ +++
Mi and Mci −−− ++ −−− ++ −− −−− +++ +++
Ma +++ +++ −− +++ −−− +++ −−− −−−
Total T cells +++ ++ +++ −− +++ −−− +++ −−− −−−
Tγ +++ ++ +++ −− +++ −−− +++ −−− −−−
Tc +++ ++ +++ −− +++ −−− +++ −−− −−−
Treg +++ + +++ −− +++ −−− +++ −−− −−−
TISSUE-LEVEL OUTPUTS
Caseation −−− +++ −− − +++ −−− +++ −−− −−−
Granuloma size −−− −− +++ +++ −−− +++ −−− −−
TISSUE CONCENTRATIONS
[sTNF]avg +++ ++ ++ −
[Chemokines]avg +++ −−− +++ +++ +++ −−− +++ −−− −−
Parameter deﬁnitions are presented inTable A5 in Appendix.
Only parameters with signiﬁcant PRCC values are indicated. Signiﬁcant positive and negative correlations are shown using ± as follows:
−/+, 0.001<p-value<0.01.
−−/++, 0.0001<p-value<0.001.
−−−/+++, p-value<0.0001.
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